Buscar
Mostrando ítems 1-10 de 105
HIV-1 resistance patterns to integrase inhibitors in Chilean patients with virological failure on raltegravir-containing regimens
(Mediscript, 2020)
In this viewpoint we would like to describe our results in terms of resistance pattern in Chilean patients with virological failure (VF) on raltegravir (RAL)-containing-regimens and highlight the need for the concomitant ...
Lack of Primary Mutations Associated With Integrase Inhibitors Among HIV-1 Subtypes B, C, and F Circulating in Brazil
(Lippincott, Williams & Wilkins, 2017)
Inibidores da HIV-integrase: Potencial abordagem farmacológica para tratamento da AIDS
(2006-06-23)
AIDS has the HIV as its etiological agent. Researches has been done to find new pharmacological agents to be used in therapy, because of problems of resistance and side effects. The HIV-integrase inhibitors are some of ...
Inibidores da HIV-integrase: Potencial abordagem farmacológica para tratamento da AIDS
(2006-06-23)
AIDS has the HIV as its etiological agent. Researches has been done to find new pharmacological agents to be used in therapy, because of problems of resistance and side effects. The HIV-integrase inhibitors are some of ...
Prevalência de mutações de resistência aos antirretrovirais em pacientes com falha virológica em uso do raltegravir em regimes de terapia de resgate
(Universidade Federal de São Paulo (UNIFESP), 2021)
The integrase enzyme is fundamental to the HIV virus replication process, being responsible for the integration of viral DNA into the host cell genome, andgenome and is therefore a potential target for rescue treatment ...